Serum lipid levels and I-PSS or Qol are not linked in prostatic hyperplasia

	Tweet

Serum lipid levels and International Prostate Symptom Score or Quality of Life Score are not linked in prostatic hyperplasia.

According to recent research from Turkey, “The relationship between serum lipid levels and measures of benign prostatic hyperplasia was investigated. The study was community based. All the participants had undergone a urological investigation which included International Prostate Symptom Score (I-PSS) and Quality of Life Score (QoL), serum lipid concentrations and determination of prostate volume with transrectal ultrasonography.”

“Body mass index was calculated with the formula of weight (kg)/surface area (m(2)) respectively. Men were considered obese if their body mass index was over 25 kg/m(2). BPH was defined by prostate volume greater than 20 ml and I-PSS greater than seven. Comparisons of serum lipid levels between men with BPH and without BPH were done,” wrote M. Lekili and associates at Celal Bayar University.

Investigators found “no correlation for serum lipid levels with either mean I-PSS and QoL scores. However, triglyceride and cholesterol levels were the lowest in severe symptomatic men than men with low symptoms. Using clinical definition of BPH that prostate volume was greater than 20 ml and I-PSS was greater than seven, men with BPH had not significantly different serum lipid levels from men without BPH.”

The researchers concluded, “Our population-based data reflect that there was no relationship between serum lipid levels and certain physiological measures of lower urinary tract symptoms and clinical benign prostatic hyperplasia.”

Lekili and colleagues published their study in World Journal of Urology (Serum lipid levels in benign prostatic hyperplasia. World J Urol, 2006;24(2):210-213).

For additional information, contact M. Lekili, Celal Bayar University, Faculty Medical, Dept. of Urology, TR-45010 Manisa, Turkey.

Publisher contact information for the World Journal of Urology is: Springer, 233 Spring Street, New York, NY 10013, USA.

RELATED STORIES:
Tissue spacers reduce risk of rectal injury for prostate cancer patients   Trapping prostate cancer cells to keep them from spreading provides hope   Prostate cancer screening improves quality of life by catching disease before it spreads   Obesity linked to higher risk of prostate cancer progression   How Prostate Cancer Packs a Punch   Vitamin E may raise prostate cancer risk   PSA Predicts Treatment Success in Advanced Prostate Cancer   Pros and cons with “easier” prostate cancer surgery   Advanced-Stage Prostate Cancer Patients Experience 20-Year Survival Rates With Surgery   Mediterranean Diet May Help Prevent Prostate Cancer   Prostate cancer cost varies widely by treatment   Variances in patterns of care for patients with prostate cancer failing primary therapy   Study Drug Holds Promise As Alternative to Castration For Early Prostate Cancers   Aspirin, Other NSAIDs, May Prevent or Delay Enlarged Prostate   Fatherhood linked to prostate cancer risk   Prostate cancer therapy linked to bone loss   Mushroom extract may boost prostate cancer drug   Daily drinking may raise risk of several cancers   Shorter radiation course stops cancer growth in high-risk prostate cancer patients   Hormonal Dietary Supplements Might Promote Prostate Cancer Progression   On Sex After Prostate Surgery, Confusing Data   Calcium consumption may cause prostate cancer in Chinese

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]